Esperion Therapeutics
ESPR
#6822
Rank
โ‚ฌ0.41 B
Marketcap
2,13ย โ‚ฌ
Share price
8.06%
Change (1 day)
150.31%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of June 2024 : โ‚ฌ0.17 Billion

According to Esperion Therapeutics's latest financial reports the company has โ‚ฌ0.17 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ74.4 M-52.17%
2022-12-31โ‚ฌ0.15 B-32.07%
2021-12-31โ‚ฌ0.22 B-7.64%
2020-12-31โ‚ฌ0.24 B38.33%
2019-12-31โ‚ฌ0.17 B50.74%
2018-12-31โ‚ฌ0.11 B-28.74%
2017-12-31โ‚ฌ0.16 B-17.05%
2016-12-31โ‚ฌ0.20 B3.62%
2015-12-31โ‚ฌ0.19 B123.07%
2014-12-31โ‚ฌ87.02 M100.1%
2013-12-31โ‚ฌ43.49 M783.5%
2012-12-31โ‚ฌ4.92 M306.9%
2011-12-31โ‚ฌ1.2 M
2002-12-31โ‚ฌ42.9 M-46.09%
2001-12-31โ‚ฌ79.58 M6.76%
2000-12-31โ‚ฌ74.54 M1170.58%
1999-12-31โ‚ฌ5.86 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.71 B 303.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.86 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.27 B 5,157.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.13 B 5,075.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.23 B 31.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.28 B 63.74%๐Ÿ‡บ๐Ÿ‡ธ USA